newsfilter
← Latest News
GlobeNewswire·

Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026

BRISBANE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (NASDAQ:DAWN) ("Day One" or the "Company"), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for